Apimeds Pharmaceuticals US Inc

APUS | AMEX

$2.88

-$0.13 (-4.16%)

Nov 2, 2026, 12:29 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021
Cash & Equivalents	1.64M	3.46K	410.48K	6.17K	171.44K
Short-Term Investments	2M	n/a	n/a	n/a	n/a
Long-Term Investments	149.89M	n/a	n/a	n/a	n/a
Other Long-Term Assets	75.49K	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	8.05M	n/a	11.6K	n/a	n/a
Total Current Assets	13.98M	13.06K	422.08K	6.17K	172.17K
Property-Plant & Equipment	239.02K	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	150.2M	n/a	n/a	n/a	n/a
Total Assets	164.18M	13.06K	422.08K	6.17K	172.17K
Account Payables	918.65K	n/a	n/a	36.88K	10.65K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	7.59M	250K	n/a	260K	n/a
Other Current Liabilities	1.62M	180.55K	n/a	n/a	n/a
Total Current Liabilities	10.71M	1.02M	123.31K	319.78K	10.65K
Long-Term Debt	n/a	346.84K	266.89K	400K	400K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	129.45K	346.84K	266.89K	400K	400K
Total Liabilities	10.84M	1.37M	390.21K	719.78K	410.65K
Total Debt	7.76M	596.84K	266.89K	660K	400K
Book Value	153.35M	-1.36M	31.87K	-713.61K	-238.48K
Book Value Per Share	140.92	-10.70	0.25	-5.62	-1.88
Common Stock	125.76K	79.04K	205.5K	100K	100K
Retained Earnings	-10.39M	-4.39M	-3M	-2.22M	-1.56M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	153.35M	-1.36M	31.87K	-713.61K	-238.48K
Total Investments	151.89M	n/a	n/a	n/a	n/a